initial public offerings (IPOs) trading on American exchanges

Friday, January 26, 2018

=resTORbio (TORC) started trading on the Nasdaq on 26 Jan 2018

resTORbio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases primarily in the United States.

Full Time Employees: 21
Founded in 2016
Headquartered in Boston, Massachusetts

Valuation at IPO $410M
Amount Raised $85M

No comments:

Post a Comment